7,770 Shares in Lam Research Corporation $LRCX Acquired by Stoneridge Investment Partners LLC

Stoneridge Investment Partners LLC acquired a new stake in Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 7,770 shares of the semiconductor company’s stock, valued at approximately $2,277,000. Lam Research comprises approximately 1.5% of Stoneridge Investment Partners LLC’s holdings, making the stock its 12th largest position.

Several other institutional investors have also added to or reduced their stakes in LRCX. Bayban purchased a new stake in shares of Lam Research during the fourth quarter valued at $26,000. Vermillion Wealth Management Inc. purchased a new position in Lam Research in the 1st quarter worth about $26,000. Cedar Mountain Advisors LLC raised its position in Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after buying an additional 85 shares during the last quarter. Mcguire Capital Advisors Inc. bought a new position in Lam Research during the 4th quarter valued at about $27,000. Finally, Triumph Capital Management bought a new position in Lam Research during the 3rd quarter valued at about $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $310.17 on Tuesday. The firm’s 50 day moving average price is $335.90 and its 200-day moving average price is $286.99. Lam Research Corporation has a twelve month low of $94.11 and a twelve month high of $438.50. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $388.12 billion, a PE ratio of 53.85, a price-to-earnings-growth ratio of 1.25 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The firm’s revenue was up 30.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts expect that Lam Research Corporation will post 9.32 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently commented on LRCX. TD Cowen reiterated a “buy” rating and issued a $400.00 price target (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Mizuho increased their price objective on shares of Lam Research from $380.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Wells Fargo & Company restated an “overweight” rating and issued a $350.00 target price (down from $450.00) on shares of Lam Research in a report on Thursday, July 30th. Bank of America lifted their target price on shares of Lam Research from $330.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Finally, Morgan Stanley decreased their target price on shares of Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $358.47.

Insiders Place Their Bets

In other news, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the firm’s stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 80,441 shares of company stock worth $27,614,296. Company insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.